Top compounds associated with response to OTUD6A


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.046 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.11 0.2
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC -0.052 0.2
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.07 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA brivanib CTRPv2 pan-cancer AAC -0.049 0.2
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.046 0.2
Download CSV